(Total Views: 560)
Posted On: 04/19/2020 12:45:57 PM
Post# of 153773
"Given that the share price could reach $18 within a year,..."
___________________________
$18?! On what revenues? Even if the BLA for combo is filed in May it could be approved if at all around Nov-Dec of this year. No time left for marketing it let alone selling in any meaningful quantities. The only other theoretical possibility is getting the CV indication approved sometime by the end of the summer, submitting the BLA (late fall) and getting it approved by the FDA in early 2021. So where is our beef in 2020--Q 1-2 2021?
___________________________
$18?! On what revenues? Even if the BLA for combo is filed in May it could be approved if at all around Nov-Dec of this year. No time left for marketing it let alone selling in any meaningful quantities. The only other theoretical possibility is getting the CV indication approved sometime by the end of the summer, submitting the BLA (late fall) and getting it approved by the FDA in early 2021. So where is our beef in 2020--Q 1-2 2021?
(0)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
